What is Zacks Research’s Estimate for CME Group Q4 Earnings?

CME Group Inc. (NASDAQ:CME) – Zacks Research cut their Q4 2025 earnings per share estimates for CME Group in a report issued on Wednesday, November 12th. Zacks Research analyst Team now forecasts that the financial services provider will post earnings of $2.60 per share for the quarter, down from their prior forecast of $2.65. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s Q1 2026 earnings at $2.88 EPS, Q2 2026 earnings at $2.91 EPS, Q3 2026 earnings at $2.81 EPS, Q4 2026 earnings at $2.94 EPS, FY2026 earnings at $11.54 EPS, Q1 2027 earnings at $2.73 EPS and Q2 2027 earnings at $3.09 EPS.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the business posted $2.68 earnings per share. CME Group’s revenue was down 3.0% compared to the same quarter last year.

A number of other research firms also recently commented on CME. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. UBS Group decreased their price target on CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday, October 23rd. Oppenheimer raised their price objective on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Argus reduced their price objective on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Finally, Raymond James Financial lowered their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $287.06.

CME Group Stock Performance

NASDAQ:CME opened at $283.54 on Thursday. The firm’s fifty day simple moving average is $266.87 and its 200-day simple moving average is $272.73. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $102.24 billion, a PE ratio of 27.47, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38. CME Group has a fifty-two week low of $222.56 and a fifty-two week high of $290.79.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Insider Buying and Selling

In related news, insider Sunil Cutinho sold 11,896 shares of the business’s stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 14,043 shares of company stock valued at $3,791,486. Company insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Institutional investors have recently modified their holdings of the company. AIA Group Ltd raised its position in shares of CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after buying an additional 2,510 shares in the last quarter. Lockheed Martin Investment Management Co. increased its stake in shares of CME Group by 34.1% during the first quarter. Lockheed Martin Investment Management Co. now owns 58,690 shares of the financial services provider’s stock valued at $15,570,000 after acquiring an additional 14,910 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in CME Group by 20.1% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 8,894 shares of the financial services provider’s stock worth $2,359,000 after purchasing an additional 1,491 shares in the last quarter. Truist Financial Corp lifted its position in CME Group by 10.0% in the second quarter. Truist Financial Corp now owns 64,939 shares of the financial services provider’s stock worth $17,898,000 after purchasing an additional 5,914 shares during the period. Finally, Heritage Investors Management Corp acquired a new stake in CME Group in the first quarter worth approximately $298,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.